SIG-002
N/A
Report date: 2023/02/01 11:19:52
Base Information
Drug NameSIG-002
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSigilon Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesArugula Sciences LLCEli Lilly And Company
Inactive CompaniesSigilon Therapeutics Inc
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A